← All organizations
Highest phase reached
Phase 3
First clinical trial
Jan 14, 2004Last known activity
Dec 5, 2025
Timeline
2000s
- Jun 1, 2002
Cellectar, Inc— Founded
Drugs by trial phase (11 distinct, 16 trials)
Phase 3 (4 own, 0 via acquisition)
Phase 2 (4 own, 0 via acquisition)
Phase 1 (3 own, 0 via acquisition)
Indications
Studied for
- Brain Neoplasms
- Carcinoma, Non-Small-Cell Lung
- Carcinoma, Ovarian Epithelial
- Glioblastoma
- Glioma
- Head and Neck Neoplasms
- Hepatitis
- Hepatitis A
- Hepatitis C
- Leukemia, Lymphocytic, Chronic, B-Cell
- Lung Neoplasms
- Lymphoma
- Lymphoma, Large B-Cell, Diffuse
- Lymphoma, Mantle-Cell
- Multiple Myeloma
- Myelodysplastic Syndromes
- Neoplasms
- Neoplasms, Plasma Cell
- Neuroblastoma
- Osteosarcoma
- Ovarian Neoplasms
- Preleukemia
- Rhabdomyosarcoma
- Sarcoma
- Sarcoma, Ewing
- Syndrome
- Waldenstrom Macroglobulinemia
Recent trials (17)
- NCT07311993Lead sponsorPhase 1Dec 5, 2025
- NCT05610891Lead sponsorPhase 1Nov 30, 2022
- NCT04105543CollaboratorPhase 1Oct 31, 2019
- NCT03478462Lead sponsorPhase 1Jul 31, 2018
- NCT02952508Lead sponsorPhase 2Dec 1, 2016
- NCT02278315Lead sponsorPhase 1Feb 1, 2015
- NCT01778088Lead sponsorPhase 2May 1, 2014
- NCT01898273Lead sponsorPhase 2Feb 1, 2014
- NCT01495663Lead sponsorPhase 1Dec 1, 2011
- NCT01058512Lead sponsorPhase 2Mar 1, 2010
- NCT00960726CollaboratorPhase 2Aug 17, 2009
- NCT00925275Study directorPhase 1Jun 1, 2009
- NCT00925275Lead sponsorPhase 1Jun 1, 2009
- NCT00347412Lead sponsorPhase 3Nov 1, 2006
- NCT00372983Lead sponsorPhase 1Aug 1, 2006
Details
- Founded
- Madison, WI, US Jun 1, 2002
- Last known activity
- Dec 5, 2025